Company intelligence / Profile preview

Medisol

Lyon, Auvergne-Rhône-Alpes, Francemedisolinternational.com ↗

Ownership: Private
Development stage: Commercial

Overview

Medisol has developed and commercialized a portfolio of seven generic injectable products across four therapeutic areas. The company’s products are distributed to both hospitals and retail pharmacies throughout France. No specific clinical trial results disclosed; as a generics manufacturer, clinical development focuses on bioequivalence rather than novel efficacy data.

Therapeutic areas: CardiovascularImmunologyNeurologyWomen's Health
Modalities: Small moleculeInjectable drug products
Industry: Biotech

Partnerships

No major external partnerships disclosed beyond parent Lupin.

Beyond the preview

Go deeper on Medisol.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medisol.

Explore the full profile